Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001185185-19-001771
Filing Date
2019-12-31
Accepted
2019-12-31 16:05:04
Documents
52
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K angiosoma20190930_10k.htm 10-K 817627
2 EXHIBIT 21 ex_168193.htm EX-21 1936
3 EXHIBIT 31.1 ex_168194.htm EX-31.1 9125
4 EXHIBIT 32.1 ex_168195.htm EX-32.1 6498
11 angiosoma20190930_10kimg001.jpg GRAPHIC 7214
  Complete submission text file 0001185185-19-001771.txt   3288370

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT soan-20190930.xml EX-101.INS 457089
6 XBRL TAXONOMY EXTENSION SCHEMA soan-20190930.xsd EX-101.SCH 31196
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE soan-20190930_cal.xml EX-101.CAL 27922
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE soan-20190930_def.xml EX-101.DEF 181806
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE soan-20190930_lab.xml EX-101.LAB 288682
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE soan-20190930_pre.xml EX-101.PRE 186978
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Filer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-55072 | Film No.: 191319519
SIC: 2834 Pharmaceutical Preparations